Management of gastrointestinal disorders in children with HIV infection

Pediatric Drugs

Volumn 6, Issue 6, 2004, Pages 347-362

  Guarino, Alfredo ^a   Bruzzese, Eugenia ^a   De Marco, Giulio ^a   Buccigrossi, Vittoria ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTIRETROVIRUS AGENT; AZITHROMYCIN; CEFIXIME; CEFOTAXIME; CEFTRIAXONE; CIPROFLOXACIN; COLESTYRAMINE; COTRIMOXAZOLE; DIDANOSINE; ERYTHROMYCIN; ETHAMBUTOL; FURAZOLIDONE; GENTAMICIN; HUMAN IMMUNOGLOBULIN; METRONIDAZOLE; OFLOXACIN; PAROMOMYCIN; PEGINTERFERON ALPHA2A; PROTEINASE INHIBITOR; RIBAVIRIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; SPIRAMYCIN; TINIDAZOLE; UNINDEXED DRUG; VANCOMYCIN;

ABDOMINAL PAIN; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANOREXIA; CHRONIC LIVER DISEASE; CONSTIPATION; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; CYTOMEGALOVIRUS; DIAGNOSTIC APPROACH ROUTE; DIARRHEA; DIET SUPPLEMENTATION; DISEASE EXACERBATION; DISEASE SEVERITY; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HEALTH CARE COST; HEPATOMEGALY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERBILIRUBINEMIA; INTESTINE FUNCTION DISORDER; LIVER DYSFUNCTION; LIVER INJURY; LIVER TOXICITY; MALNUTRITION; MICROBIOLOGICAL EXAMINATION; MYCOBACTERIUM; NAUSEA; OPPORTUNISTIC INFECTION; PANCREAS DISEASE; PANCREATITIS; PARENTERAL NUTRITION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIDE EFFECT; STEATOSIS; SYMPTOMATOLOGY; VOMITING;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; CHILD; DISEASE MANAGEMENT; GASTROINTESTINAL DISEASES; HIV; HUMANS; ITALY;

EID: 11244313888     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00148581-200406060-00003     Document Type: Review

References (79)

1. Mofenson LM. Pediatric HIV infection in developed and developing countries: epidemiology and natural history. In: Shearer WT, Hanson IC, editors. Medical management of AIDS in children. Philadelphia (PA): Saunders, 2003: 1-28
2. Selik RM. Lindegren ML. Changes in deaths reported with human immunodeficiency virus infection among United States children less than thirteen years old, 1987 through 1999. Pediatr Infect Dis J 2003; 22: 635-41
3. Gibb DM, Duong T. Tookey PA. et al. Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland. BMJ 2003; 327 (7422): 1019
4. Lindegren ML, Steinberg S, Byers Jr RH. Epidemiology of HIV/AIDS in children. Pediatr Clin North Am 2000; 47: 1-20
5. Centers for Disease Control and Prevention. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Morb Mortal Wkly Rep 1994; 43: 1-10
6. Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the use of antiretroviral agents in pediatric HlV infection [online]. Available from URL: http://www.aidsinfo.nih. gov/guidelines/pediatric/PED_012004.html [Accessed 2004 Jan 23]
7. Chantry CJ, Moye Jr J, Winter HS. Nutritional monitoring and support. In: Zeichner SL, Read JS, editors. Handbook of pediatric HIV care. Philadelphia (PA): Lippincott Williams & Wilkins. 1999: 188-209
8. Obimbo EM, Mbori-Ngacha DA, Oehieng JO, et al. Predictors of early mortality in a cohort of human immunodeficiency virus type 1-infected African children. Pediatr Infect Dis J 2004; 23: 536-43
9. Guarino A, Castaldo A, Russo S, et al. Enteric cryptosporidiosis in pediatric HIV-infection. J Pediatr Gastroenterol Nutr 1997; 25: 182-7
10. Monkemuller KE, Call SA, Lazenby AJ, et al. Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy. Am J Gastroenterol 2002; 95: 457-62
11. Guarino A, Albano F. Guidelines for the approach to outpatient children with acute diarrhoea. Acta Paediatr 2001; 90: 1087-95
12. Keusch GT, Thea DM, Kamenga M. et al. Persistent diarrhea associated with AIDS. Acta Paediatr Suppl 1992; 381: 45-8
13. 3. Am J Gastroenterol 2002; 95: 3142-6
14. Chen XM, Keithly JS, Paya CV, et al. Cryptosporidiosis. N Engl J Med 2002; 346: 1723-31
15. Koch J, Owen RL. Small intestine pathogens in AIDS: conventional and opportunistic. Gastrointest Endosc Clin N Am 1998; 8: 869-88
16. Goodgame RW, Kimball K, Ou CN, et al. Intestinal function and injury in acquired immunodeficiency syndrome-related cryptosporidiosis. Gastroenterology 1995; 108: 1075-82
17. Kosek M, Alcantara C, Lima AA, et al. Cryptosporidiosis: an update. Lancet Infect Dis 2001; I: 262-9
18. Guarino A, Berni Canani R, Casola A. et al. Human intestinal cryptosporidiosis: secretory diarrhea and enterotoxic activity in Caco-2 cells. J Infect Dis 1995: 171: 976-83
19. Obi CL, Bessong PO. Diarrhoeagenic bacterial pathogens in HIV-positive patients in rural communities of Limpopo province, South Africa. J Health Popul Nutr 2002; 20: 230-4
20. Welage LS, Carver PL, Reyankar S, et al. Alterations in gastric acidity in patients infected with human immunodeficiency virus. Clin Infect Dis 1995; 21: 1431-8
21. Parashar UD, Hummelmann E. Brese JS, et al. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003; 9: 565-72
22. Cunliffe NA, Gondwe JS, Kirkwood CD, et al. Effect of concomitant HIV infection on presentation and outcome of gastroenteritis in Malawian children. Lancet 2001; 358: 550-5
23. Guarino A, Russo S, Castaldo A. et al. Passive immunotherapy for rotavirus-induced diarrhoea in children with HIV infection. AIDS 1996; 10: 1176-8
24. Ukarapol N, Chartapisak W, Lertprasertsuk N, et al. Cytomegalovirus- associated manifestations involving the digestive tract in children with human immunodeficiency virus infection. J Pediatr Gastroenterol Nutr 2002; 35: 669-73
25. Keusch GT, Thea DM, Kamenga M. et al. Persistent diarrhea associated with AIDS. Acta Paediatr 1992: 381: 45-8
26. Jirapinyo P, Brewster D, Succi RC, et al. HIV disease: Working Group Report of the First World Congress of Pedatric Gastroenterology, Hepatology. and Nutrition. J Pediatr Gastroenterol Nutr 2002; 35 Suppl. 2: S134-42
27. Cohen J, West AB, Bini EJ. Infectious diarrhea in human immunodeficiency virus. Gastroenterol Clin North Am 2001; 30: 637-64
28. Ramos-Soriano AG, Saavedra JM, Wu TC, et al. Enteric pathogens associated with gastrointestinal dysfunction in children with HIV infection. Mol Cell Probes 1996; 10: 67-73
29. Berni Canani R, Cirillo P, Mallardo G, et al. Effects of HIV-1 TAT protein on ion secretion and on cell proliferation in human intestinal epithelial cells. Gastroenterology 2003; 124: 368-76
30. Wilcox CM, Rabeneck L. Friedman S. AGA technical review: malnutrition and cachexia, chronic diarrhea and hepatobiliary disease in patients with human immunodeficiency virus infection. Gastroenterology 1996; 111: 1724-36
31. The Italian Paediatric Intestinal/HIV Study Group. Intestinal malabsorption of HIV-infected children: relationship to diarrhoea, failure to thrive, enteric micro-organisms and immune impairment. AIDS 1993; 7: 1435-40
32. Guarino A. Albano F. Viral diarrhea. In: Guandalini S, editor. Textbook of pediatric gastroenterology. London: Martin Dunitz Ltd, 2004: 127-44
33. Ball SC. Diarrhea in a patient with AIDS. AIDS Read 2002; 12: 380-8
34. Miller TL, McQuinn LB, Orav EJ. Endoscopy of the upper gastrointestinal tract as a diagnostic tool for children with human immunodeficiency virus infection. J Pediatr 1997; 130: 767-73
35. Arico M, Caselli D, D'Argenio P, et al. Malignancies in children with human immunodeficiency virus type I infection: the Italian Multicenter Study on Human Immunodeficiency Virus Infection in Children. Cancer 1991; 68: 2473-7
36. Guarino A, Tarallo L, Guandalini S, et al. Impaired intestinal function in symptomatic HIV infection. J Pediatr Gastroenterol Nutr 1991; 12: 452-8
37. Zulu I, Veitch A, Sianongo S. et al. Albendazole chemotherapy for AIDS-related diarrhoea in Zambia: clinical, parasitological and mucosal responses. Aliment Pharmacol Ther 2002; 16: 595-601
38. Amadi B, Mwiya M. Musuku J. et al. Effect of nitazoxamide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomized controlled trial. Lancet 2002; 360: 1375-80
39. Greenberg PD, Cello JP. Treatment of severe diarrhea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13: 348-54
40. Guarino A, Berni Canani R, Spagnuolo MI, et al. In vivo and in vitro efficacy of octreotide for treatment of enteric cryptosporidiosis. Dig Dis Sci 1998: 43: 436-41
41. Gibb DM, Newberry A, Klein N, et al. Immune repopulation after HAART in previously treated HIV-1-infected children: Paediatric European Network for Treatment of AIDS (PENTA) Steering Committee. Lancet 2000; 355: 1331-2
42. Guarino A, Albano F, Berni Canani R, et al. HIV, fatal rotavirus infection, and treatment options. Lancet 2002; 359: 74
43. Simonsen L, Morens DM, Elixhauser A, et al. Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception. Lancet 2001; 358: 1224-9
44. Kimberlin DW. Antiviral therapy for cytomegalovirus infections in pediatric patients. Semin Pediatr Infect Dis 2002; 13: 22-30
45. Shafran S, Singer J, Zarowny D, et al. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. N Engl J Med 1996; 335: 377-83
46. Neild PJ, Evans DF, Castillo FD, et al. Effect of octreotide on small intestinal motility in HIV-infected patients with chronic refractory diarrhea. Dig Dis Sci 2001; 46: 2636-42
47. Minton NA, Henry JA. Loperamide poisoning in children. Lancet 1990; 335: 788
48. Tovo PA, de Martine M, Gabiano C, et al. Prognostic factors and survival in children with perinatal HIV-1 infection. Lancet 1992; 339: 1249-53
49. Castaldo A, Tarallo L, Palomba E, et al. Iron deficiency and intestinal malabsorption in HIV disease. J Pediatr Gastroenterol Nutr 1996; 22: 359-63
50. Zuin G, Fontana M, Monti S, et al. Malabsorption of different lactose loads in children with human immunodeficiency virus infection. J Pediatr Gastroenterol Nutr 1992; 15: 408-12
51. Carroccio A, Fontana M, Spagnuolo MI, et al. Pancreatic dysfunction and its association with fat malabsorption in HIV infected children. Gut 1998; 43: 558-63
52. Berni Canani R, Spagnuolo MI, Cirillo P, et al. Ritonavir combination therapy restores intestinal function in children with advanced HIV disease. J Acquir Immune Defic Syndr 1999; 21; 307-12
53. Ferrero S, Lungaro P, Bruzzone BM, et al. Prospective study of mother-to-infant transmission of hepatitis C virus: a 10-year survey (1990-2000). Acta Obstet Gynecol Scand 2003; 82: 229-34
54. Chung RT, Andersen J, Volberding P, et al. Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med 2004; 351: 451-9
55. Resti M, Azzari C, Bortolotti F. Hepatitis C virus infection in children coinfected with HIV: epidemiology and managment. Pediatr Drugs 2002; 4: 571-80
56. Piliero PJ, Paragon JJ. Hepatitis B virus and HIV coinfection. AIDS Read 2002; 12:443-51
57. Centers for Disease Control and Prevention. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA). Morbidity and Mortality Weekly Report 1999; 48 RR 10: 1-59
58. Chui DW, Owen RL. AIDS and the gut. J Gastroenterol Hepatol 1994; 9: 291-303
59. Montessori V, Harris M, Montaner JS. Hepatotoxicity of nucleoside reverse transcriptase inhibitors. Semin Liver Dis 2003; 23: 167-72
60. Dieterich DT. Long-term complications of nucleoside reverse transcriptase inhibitor therapy. AIDS Read 2003; 13; 176-84
61. Carroccio A, Guarino A, Zuin G, et al. Efficacy of oral pancreatic enzyme therapy for the treatment of fat malabsorption in HIV-infected patients. Aliment Pharmacol Ther 2001; 15: 1619-25
62. Beisel WR. Nutrition and immune function: overview. J Nutr 1996; 126: 2611S-5S
63. Heller L, Fox S, Hell KJ, et al. Development of an instrument to assess nutritional risk factors for children with human immunodeficiency virus. J Am Diet Assoc 2000; 100: 323-9
64. Miller TL. Nutritional aspects of HIV-infected children receiving highly active antiretroviral therapy. AIDS 2003; 17 Suppl. 1: S130-40
65. Johann-Liang R, O'Neill L, Cervia J, et al. Energy balance, viral burden, insulin-like growth factor-1, interleukin 6 and growth impairment in children infected with human immunodeficiency virus. AIDS 2000; 14: 683-90
66. Miller TL. Nutrition in paediatric human immunodeficiency virus infection. Proc Nutr Soc 2000; 59: 155-62
67. Miller TL, Mawn BE, Orav J, et al. The effect of protease inhibitor therapy on growth and body composition in human immunodeficiency virus type 1-infected children. Pediatrics 2001; 107: e77
68. Clarick RH, Hanekom WA, Yogev R, et al. Megestrol acetate treatment of growth failure in children infected with human immunodeficiency virus. Pediatrics 1997; 99: 354-7
69. Goulet O, Colomb V. Enteral nutrition. In: Guandalini S, editor. Textbook of pediatric gastroenterology. London: Martin Dunitz Ltd, 2004: 539-54
70. Guarino A, Spagnuolo MI, Giacomet V, et al. Effects of nutritional rehabilitation on intestinal function and on CD4 cell number in children with HIV. J Pediatr Gastroenterol Nutr 2002; 34: 366-71
71. Villamor E, Mbise R, Spegelman D, et al. Vitamin A supplements ameliorate the adverse effects of HIV-1, malaria, and diarrheal infections on child growth. Pediatrics 2002; 109: e6
72. Duggan C, Fawzie W. Micronutrients and child health: studies in international nutrition and HIV infection. Nutr Rev 2001; 59: 358-69
73. Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet 2000; 356: 1423-30
74. Sulkowski MS, Thomas DL, Mehta SH, et al. Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections. Hepatology 2002; 35: 182-9
75. Butler KM, Venzon D, Henry N, et al. Pancreatitis in human immunodeficiency virus-infected children receiving dideoxyinosine. Pediatrics 1993; 91: 747-51
76. The Division of Microbiology and Infectious Diseases (DMID). Pediatric toxicity tables [online]. Available from URL: http//:www.icssc.org/Documents/ AE%20Manual%202003%20Appendices%20February_06_2003%20final.pdf pp. 60-70 [Accessed 2003 Mar 6]
77. Ammassari A, Murri R, Pezzotti P, et al. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr 2001; 28: 445-9
78. McCabe RP. Gastrointestinal manifestations of non-AIDS immunodeficiency. Curr Treat Options Gastroenterol 2002; 5: 17-25
79. Wittenberg D, Benitez CV, Canani RB, et al. HIV infection: Working Group Report of the Second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2004; 39: S640-6